We hypothesize that TREX1 functions as an “innate immune checkpoint” in prostate cancer by attenuating cGAS-STING signaling, thereby facilitating immune evasion and disease progression; nonetheless, this proposition warrants further experimental validation. Here, CGAS is linked to Familial prostate cancer.